Andrew D Chung1, Nicola Schieda1, Trevor A Flood2, Ilias Cagiannos3, Kien T Mai2, Shawn Malone4, Christopher Morash3, Shaheed W Hakim2, Rodney H Breau3. 1. Department of Medical Imaging; The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada. 2. Department of Anatomical Pathology; The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada. 3. Department of Surgery, Division of Urology; The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada. 4. Department of Radiation Oncology; The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada.
Abstract
INTRODUCTION: Plasmacytoid urothelial carcinoma (PUC) is a high-grade variant of conventional urothelial cell carcinoma. This study is the first to describe the imaging findings of PUC, which are previously unreported, using clinical and histopathological correlation. METHODS: With internal review board approval, we identified 22 consecutive patients with PUC from 2007-2014. Clinical parameters, including age, gender, therapy, surgical margins, and long-term outcome, were recorded. Baseline imaging was reviewed by an abdominal radiologist who evaluated for tumour detectability/location/morphology, local staging, and presence/location of metastases. Pelvic peritoneal spread of tumour (defined as >5mm thick soft tissue spreading along fascial planes) was also evaluated. Followup imaging was reviewed for presence of local recurrence or metastases. RESULTS: Median age at presentation was 74 years (range 51-86), with only three female patients. Imaging features of the primary tumour in this study were not unique for PUC. Muscle-invasive disease was present on pathology in 19/22 (86%) of tumours, with distant metastases in 2/22 (9%) at baseline imaging. Pelvic peritoneal spread of tumour was radiologically present in 4/20 (20%) at baseline. During followup, recurrent/residual tumour was documented in 16/22 (73%) patients and 7/16 (44%) patients eventually developed distant metastases. Median time to disease recurrence in patients who underwent curative surgery was three months (range 0-19). CONCLUSIONS: PUC is an aggressive variant of urothelial carcinoma with poor prognosis. Pelvic peritoneal spread of tumour as thick sheets extending along fascial planes may represent a characteristic imaging finding of locally advanced PUC.
INTRODUCTION: Plasmacytoid urothelial carcinoma (PUC) is a high-grade variant of conventional urothelial cell carcinoma. This study is the first to describe the imaging findings of PUC, which are previously unreported, using clinical and histopathological correlation. METHODS: With internal review board approval, we identified 22 consecutive patients with PUC from 2007-2014. Clinical parameters, including age, gender, therapy, surgical margins, and long-term outcome, were recorded. Baseline imaging was reviewed by an abdominal radiologist who evaluated for tumour detectability/location/morphology, local staging, and presence/location of metastases. Pelvic peritoneal spread of tumour (defined as >5mm thick soft tissue spreading along fascial planes) was also evaluated. Followup imaging was reviewed for presence of local recurrence or metastases. RESULTS: Median age at presentation was 74 years (range 51-86), with only three female patients. Imaging features of the primary tumour in this study were not unique for PUC. Muscle-invasive disease was present on pathology in 19/22 (86%) of tumours, with distant metastases in 2/22 (9%) at baseline imaging. Pelvic peritoneal spread of tumour was radiologically present in 4/20 (20%) at baseline. During followup, recurrent/residual tumour was documented in 16/22 (73%) patients and 7/16 (44%) patients eventually developed distant metastases. Median time to disease recurrence in patients who underwent curative surgery was three months (range 0-19). CONCLUSIONS: PUC is an aggressive variant of urothelial carcinoma with poor prognosis. Pelvic peritoneal spread of tumour as thick sheets extending along fascial planes may represent a characteristic imaging finding of locally advanced PUC.
Authors: Wassim Kassouf; Samer L Traboulsi; Girish S Kulkarni; Rodney H Breau; Alexandre Zlotta; Andrew Fairey; Alan So; Louis Lacombe; Ricardo Rendon; Armen G Aprikian; D Robert Siemens; Jonathan I Izawa; Peter Black Journal: Can Urol Assoc J Date: 2015-10-13 Impact factor: 1.862
Authors: Atul B Shinagare; Nikhil H Ramaiya; Jyothi P Jagannathan; Fiona M Fennessy; Mary-Ellen Taplin; Annick D Van den Abbeele Journal: AJR Am J Roentgenol Date: 2011-01 Impact factor: 3.959
Authors: Farshid Dayyani; Bogdan A Czerniak; Kanishka Sircar; Mark F Munsell; Randall E Millikan; Colin P Dinney; Arlene O Siefker-Radtke Journal: J Urol Date: 2012-11-15 Impact factor: 7.450
Authors: Bastian Keck; Sven Wach; Robert Stoehr; Frank Kunath; Simone Bertz; Jan Lehmann; Michael Stöckle; Helge Taubert; Bernd Wullich; Arndt Hartmann Journal: BMC Cancer Date: 2013-02-08 Impact factor: 4.430